|
GB9120306D0
(en)
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
|
US20040126396A1
(en)
*
|
1993-12-28 |
2004-07-01 |
Allergan, Inc. |
Botulinum toxin treatment for strabismus
|
|
US8557256B2
(en)
*
|
1993-12-28 |
2013-10-15 |
Allergan, Inc. |
Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
|
|
US6974578B1
(en)
*
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
|
US8187612B2
(en)
*
|
1993-12-28 |
2012-05-29 |
Allergan, Inc. |
Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
|
|
US9375573B2
(en)
|
1998-08-05 |
2016-06-28 |
Cyberonics, Inc. |
Systems and methods for monitoring a patient's neurological disease state
|
|
US9415222B2
(en)
|
1998-08-05 |
2016-08-16 |
Cyberonics, Inc. |
Monitoring an epilepsy disease state with a supervisory module
|
|
US7747325B2
(en)
|
1998-08-05 |
2010-06-29 |
Neurovista Corporation |
Systems and methods for monitoring a patient's neurological disease state
|
|
US7277758B2
(en)
|
1998-08-05 |
2007-10-02 |
Neurovista Corporation |
Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
|
|
US9042988B2
(en)
|
1998-08-05 |
2015-05-26 |
Cyberonics, Inc. |
Closed-loop vagus nerve stimulation
|
|
US7242984B2
(en)
|
1998-08-05 |
2007-07-10 |
Neurovista Corporation |
Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
|
|
US7209787B2
(en)
|
1998-08-05 |
2007-04-24 |
Bioneuronics Corporation |
Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
|
|
US7403820B2
(en)
|
1998-08-05 |
2008-07-22 |
Neurovista Corporation |
Closed-loop feedback-driven neuromodulation
|
|
US7231254B2
(en)
|
1998-08-05 |
2007-06-12 |
Bioneuronics Corporation |
Closed-loop feedback-driven neuromodulation
|
|
US7324851B1
(en)
|
1998-08-05 |
2008-01-29 |
Neurovista Corporation |
Closed-loop feedback-driven neuromodulation
|
|
US9113801B2
(en)
|
1998-08-05 |
2015-08-25 |
Cyberonics, Inc. |
Methods and systems for continuous EEG monitoring
|
|
US8762065B2
(en)
|
1998-08-05 |
2014-06-24 |
Cyberonics, Inc. |
Closed-loop feedback-driven neuromodulation
|
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US6306403B1
(en)
*
|
2000-06-14 |
2001-10-23 |
Allergan Sales, Inc. |
Method for treating parkinson's disease with a botulinum toxin
|
|
MXPA03000014A
(es)
*
|
2000-06-28 |
2004-09-13 |
Ira Sanders |
Metodos para utilizar con fines beneficiosos toxina tetanica en animales.
|
|
US20040219619A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Ester Fernandez-Salas |
Methods of identifying compounds that alter toxin persistence and/or protease activity
|
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
|
US7491799B2
(en)
*
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
US7691983B2
(en)
*
|
2000-07-21 |
2010-04-06 |
Allergan, Inc. |
Chimera botulinum toxin type E
|
|
EP1339438B1
(de)
|
2000-11-29 |
2005-10-19 |
Allergan Inc. |
Verhinderung von transplantatabstossung im auge
|
|
US7749539B2
(en)
*
|
2000-11-30 |
2010-07-06 |
Efrat Biopolymers Ltd. |
Polymeric formulations for drug delivery
|
|
JP4707254B2
(ja)
*
|
2001-04-24 |
2011-06-22 |
クミアイ化学工業株式会社 |
粒状組成物及びその製造方法
|
|
US6984375B2
(en)
*
|
2001-08-03 |
2006-01-10 |
Allergan, Inc. |
Nuclei density and nuclei area methods for determining effects of a botulinum toxin on muscles
|
|
US20030105409A1
(en)
|
2001-11-14 |
2003-06-05 |
Donoghue John Philip |
Neurological signal decoding
|
|
KR20100135884A
(ko)
*
|
2001-11-15 |
2010-12-27 |
마이크로 알제 코포레이션 |
3, 4-프로피온퍼하이드로퓨린을 포함하는 약학 조성물 및 상기 조성물을 이용한 신경 전달의 블로킹 방법
|
|
JPWO2003082315A1
(ja)
*
|
2002-03-29 |
2005-07-28 |
財団法人化学及血清療法研究所 |
筋緊張亢進疾患治療剤
|
|
US20040058313A1
(en)
*
|
2002-04-24 |
2004-03-25 |
Abreu Marcio Marc |
Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
|
|
US6921538B2
(en)
*
|
2002-05-10 |
2005-07-26 |
Allergan, Inc. |
Therapeutic treatments for neuropsychiatric disorders
|
|
US7691394B2
(en)
*
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
|
EP1513584A2
(de)
*
|
2002-06-04 |
2005-03-16 |
Cyberkinetics, Inc. |
Optisch verbundene implantate, darauf bezogene systeme und deren verwendung
|
|
US7212851B2
(en)
*
|
2002-10-24 |
2007-05-01 |
Brown University Research Foundation |
Microstructured arrays for cortex interaction and related methods of manufacture and use
|
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
|
US7238357B2
(en)
*
|
2002-11-05 |
2007-07-03 |
Allergan, Inc. |
Methods for treating ulcers and gastroesophageal reflux disease
|
|
JP2007528352A
(ja)
*
|
2003-03-06 |
2007-10-11 |
ボツリヌム・トクシン・リサーチ・アソシエイツ・インコーポレイテッド |
洞炎に関連する慢性の顔面痛および頭痛のボツリヌス毒素での治療
|
|
WO2004078200A1
(en)
*
|
2003-03-06 |
2004-09-16 |
Botulinum Toxin Research Associates, Inc. |
Selection of patients with increased responsiveness to botulinum toxin
|
|
US7393537B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Allergan, Inc. |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder
|
|
BRPI0409744A
(pt)
*
|
2003-04-25 |
2006-05-09 |
Allergan Inc |
emprego de uma neurotoxina de botulinum para aliviar vários distúrbios
|
|
US7393538B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Ackerman Alan H |
Clostridial toxin treatment for dermatillomania
|
|
AU2011203509B2
(en)
*
|
2003-04-25 |
2014-02-06 |
Allergan, Inc. |
Botulinum neurotoxin for treating tics and obsessive compulsive behaviors
|
|
US7422753B2
(en)
*
|
2003-04-25 |
2008-09-09 |
Allergan, Inc. |
Methods for treating trichotillomania
|
|
US7396535B2
(en)
*
|
2003-04-25 |
2008-07-08 |
Ackerman Alan H |
Therapy for obsessive compulsive head banging
|
|
US7390496B2
(en)
|
2003-04-25 |
2008-06-24 |
Allergan, Inc. |
Therapeutic treatments for repetitive hand washing
|
|
US6838434B2
(en)
*
|
2003-05-02 |
2005-01-04 |
Allergan, Inc. |
Methods for treating sinus headache
|
|
US20040226556A1
(en)
|
2003-05-13 |
2004-11-18 |
Deem Mark E. |
Apparatus for treating asthma using neurotoxin
|
|
US7220422B2
(en)
*
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
|
US7704685B2
(en)
*
|
2003-05-30 |
2010-04-27 |
The Cleveland Clinic Foundation |
In vivo production of a clostridial neurotoxin light chain peptide
|
|
US20040253274A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Allergan, Inc. |
Use of a clostridial toxin to reduce appetite
|
|
US20050013850A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Caers Jan K. |
Device to assist hyperhydrosis therapy
|
|
US20050214413A1
(en)
*
|
2003-08-26 |
2005-09-29 |
Mannatech, Inc. |
Methods and compositions for modified release of nutritional supplements
|
|
TWI243696B
(en)
*
|
2003-10-15 |
2005-11-21 |
Der-Yang Tien |
System for introducing macromolecule substance into living target cell
|
|
US20110071381A1
(en)
*
|
2003-10-15 |
2011-03-24 |
Robert Tien |
Method and system for leading macromolecule substances into living target cells
|
|
US20090076391A1
(en)
*
|
2003-10-15 |
2009-03-19 |
Der-Yang Tien |
Method and system for leading macromolecule substances into living target cells
|
|
US8617572B2
(en)
|
2003-10-29 |
2013-12-31 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US8609112B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US8609113B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US8734810B2
(en)
*
|
2003-10-29 |
2014-05-27 |
Allergan, Inc. |
Botulinum toxin treatments of neurological and neuropsychiatric disorders
|
|
US20050143589A1
(en)
*
|
2003-11-09 |
2005-06-30 |
Donoghue John P. |
Calibration systems and methods for neural interface devices
|
|
US7172764B2
(en)
*
|
2003-11-17 |
2007-02-06 |
Allergan, Inc. |
Rescue agents for treating botulinum toxin intoxications
|
|
US20050113744A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Cyberkinetics, Inc. |
Agent delivery systems and related methods under control of biological electrical signals
|
|
US7751877B2
(en)
*
|
2003-11-25 |
2010-07-06 |
Braingate Co., Llc |
Neural interface system with embedded id
|
|
US20050129677A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Shengwen Li |
Lipid rafts and clostridial toxins
|
|
US20050148935A1
(en)
*
|
2003-12-29 |
2005-07-07 |
Rozalina Dimitrova |
Botulinum toxin injection guide
|
|
US7647097B2
(en)
*
|
2003-12-29 |
2010-01-12 |
Braingate Co., Llc |
Transcutaneous implant
|
|
US20050203366A1
(en)
*
|
2004-03-12 |
2005-09-15 |
Donoghue John P. |
Neurological event monitoring and therapy systems and related methods
|
|
WO2005110418A2
(en)
*
|
2004-05-07 |
2005-11-24 |
Phytotox Limited |
Transdermal administration of phycotoxins
|
|
US20080021051A1
(en)
*
|
2004-05-07 |
2008-01-24 |
Phytotox Limited |
Phycotoxins and Uses Thereof
|
|
US7514088B2
(en)
*
|
2005-03-15 |
2009-04-07 |
Allergan, Inc. |
Multivalent Clostridial toxin derivatives and methods of their use
|
|
US7811584B2
(en)
*
|
2004-06-30 |
2010-10-12 |
Allergan, Inc. |
Multivalent clostridial toxins
|
|
WO2006017179A1
(en)
|
2004-07-09 |
2006-02-16 |
Robert Sabin |
Compositions and methods of use for treatment of mammalian diseases
|
|
US8173797B2
(en)
*
|
2004-07-21 |
2012-05-08 |
Cornell Research Foundation, Inc. |
Therapeutic compounds derived from spider venom and their method of use
|
|
US20060024794A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Shengwen Li |
Novel methods for production of di-chain botulinum toxin
|
|
US20060058627A1
(en)
*
|
2004-08-13 |
2006-03-16 |
Flaherty J C |
Biological interface systems with wireless connection and related methods
|
|
WO2006026780A1
(en)
|
2004-09-01 |
2006-03-09 |
Allergan, Inc. |
Degradable clostridial toxins
|
|
WO2006034305A2
(en)
*
|
2004-09-21 |
2006-03-30 |
University Of Florida Research Foundation, Inc. |
Multiple lead method for deep brain stimulation
|
|
US20060073208A1
(en)
*
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
|
WO2006041738A2
(en)
*
|
2004-10-04 |
2006-04-20 |
Cyberkinetics Neurotechnology Systems, Inc. |
Biological interface system
|
|
US8000795B2
(en)
|
2004-12-17 |
2011-08-16 |
Lozano Andres M |
Cognitive function within a human brain
|
|
US8143368B2
(en)
*
|
2004-12-23 |
2012-03-27 |
Massachusetts Institute Of Technology |
Disposable medical supplies from hydrolytically biodegradable plastics
|
|
WO2006074029A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Cyberkinetics Neurotechnology Systems, Inc. |
Neurally controlled and multi-device patient ambulation systems and related methods
|
|
US20070032738A1
(en)
*
|
2005-01-06 |
2007-02-08 |
Flaherty J C |
Adaptive patient training routine for biological interface system
|
|
US8095209B2
(en)
*
|
2005-01-06 |
2012-01-10 |
Braingate Co., Llc |
Biological interface system with gated control signal
|
|
WO2006076175A2
(en)
*
|
2005-01-10 |
2006-07-20 |
Cyberkinetics Neurotechnology Systems, Inc. |
Biological interface system with patient training apparatus
|
|
US20060167564A1
(en)
*
|
2005-01-10 |
2006-07-27 |
Flaherty J C |
Limb and digit movement system
|
|
WO2006078432A2
(en)
*
|
2005-01-18 |
2006-07-27 |
Cyberkinetics Neurotechnology Systems, Inc. |
Biological interface system with automated configuration
|
|
US7158607B2
(en)
*
|
2005-02-10 |
2007-01-02 |
Brookhaven Science Associates, Llc |
Methods for assisting recovery of damaged brain and spinal cord using arrays of X-ray microplanar beams
|
|
US7194063B2
(en)
*
|
2005-02-10 |
2007-03-20 |
Brookhaven Science Associates, Llc |
Methods for implementing microbeam radiation therapy
|
|
US20080192892A1
(en)
*
|
2005-02-10 |
2008-08-14 |
Brookhaven Science Associates |
Methods for Implementing Microbeam Radiation Therapy
|
|
RU2007136616A
(ru)
*
|
2005-03-03 |
2009-04-10 |
Риванс Терапьютикс, Инк. (Us) |
Композиция и способ для местного применения и чрескожного введения ботулинового токсина
|
|
CA2601592A1
(en)
|
2005-03-15 |
2006-09-28 |
Allergan, Inc. |
Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
|
|
US10052465B2
(en)
|
2005-07-22 |
2018-08-21 |
The Foundry, Llc |
Methods and systems for toxin delivery to the nasal cavity
|
|
JP5826450B2
(ja)
|
2005-07-22 |
2015-12-02 |
ザ ファウンドリー， エルエルシー |
治療薬の送達のためのシステムおよび方法
|
|
US7655243B2
(en)
|
2005-07-22 |
2010-02-02 |
The Foundry, Llc |
Methods and systems for toxin delivery to the nasal cavity
|
|
US7910116B2
(en)
*
|
2005-08-24 |
2011-03-22 |
Allergan, Inc. |
Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
|
|
US20070106143A1
(en)
*
|
2005-11-08 |
2007-05-10 |
Flaherty J C |
Electrode arrays and related methods
|
|
US20070156126A1
(en)
*
|
2005-12-29 |
2007-07-05 |
Flaherty J C |
Medical device insertion system and related methods
|
|
US8868172B2
(en)
|
2005-12-28 |
2014-10-21 |
Cyberonics, Inc. |
Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
|
|
US8725243B2
(en)
|
2005-12-28 |
2014-05-13 |
Cyberonics, Inc. |
Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
|
|
US20070218084A1
(en)
*
|
2005-12-30 |
2007-09-20 |
Fondazione Pierfranco E Luisa Mariani- Onlus |
Method for the Mapping of the Epileptogenic Focus in the Pre-Surgical Evaluation of Patients with Intractable Epilepsy
|
|
US7794386B2
(en)
|
2006-03-15 |
2010-09-14 |
Allergan, Inc. |
Methods for facilitating weight loss
|
|
US7811586B2
(en)
*
|
2006-05-02 |
2010-10-12 |
Allergan, Inc. |
Methods for alleviating testicular pain
|
|
US7998128B2
(en)
*
|
2006-05-15 |
2011-08-16 |
Therataxis, LLC. |
Active delivery and flow redirection: novel devices and method of delivery of materials to patients
|
|
US20080027348A1
(en)
|
2006-06-23 |
2008-01-31 |
Neuro Vista Corporation |
Minimally Invasive Monitoring Systems for Monitoring a Patient's Propensity for a Neurological Event
|
|
US20080092910A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Allergan, Inc. |
Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures
|
|
US20080113051A1
(en)
*
|
2006-11-13 |
2008-05-15 |
Allergan, Inc. |
Methods for alleviating tattoo pain
|
|
US8295934B2
(en)
|
2006-11-14 |
2012-10-23 |
Neurovista Corporation |
Systems and methods of reducing artifact in neurological stimulation systems
|
|
WO2008092119A2
(en)
|
2007-01-25 |
2008-07-31 |
Neurovista Corporation |
Systems and methods for identifying a contra-ictal condition in a subject
|
|
WO2008092133A2
(en)
|
2007-01-25 |
2008-07-31 |
Neurovista Corporation |
Methods and systems for measuring a subject's susceptibility to a seizure
|
|
US8374673B2
(en)
|
2007-01-25 |
2013-02-12 |
Warsaw Orthopedic, Inc. |
Integrated surgical navigational and neuromonitoring system having automated surgical assistance and control
|
|
US7987001B2
(en)
|
2007-01-25 |
2011-07-26 |
Warsaw Orthopedic, Inc. |
Surgical navigational and neuromonitoring instrument
|
|
US7747551B2
(en)
*
|
2007-02-21 |
2010-06-29 |
Neurovista Corporation |
Reduction of classification error rates and monitoring system using an artificial class
|
|
US8036736B2
(en)
|
2007-03-21 |
2011-10-11 |
Neuro Vista Corporation |
Implantable systems and methods for identifying a contra-ictal condition in a subject
|
|
US20090005756A1
(en)
*
|
2007-06-29 |
2009-01-01 |
Boston Scientific Neuromodulation Corporation |
Methods and Systems of Treating Strabismus
|
|
TW200903724A
(en)
*
|
2007-07-09 |
2009-01-16 |
Ind Tech Res Inst |
Phase change memory device and method of fabricating the same
|
|
US9788744B2
(en)
|
2007-07-27 |
2017-10-17 |
Cyberonics, Inc. |
Systems for monitoring brain activity and patient advisory device
|
|
US20090171168A1
(en)
|
2007-12-28 |
2009-07-02 |
Leyde Kent W |
Systems and Method for Recording Clinical Manifestations of a Seizure
|
|
US9259591B2
(en)
|
2007-12-28 |
2016-02-16 |
Cyberonics, Inc. |
Housing for an implantable medical device
|
|
US8483831B1
(en)
|
2008-02-15 |
2013-07-09 |
Holaira, Inc. |
System and method for bronchial dilation
|
|
US8470337B2
(en)
*
|
2008-03-13 |
2013-06-25 |
Allergan, Inc. |
Therapeutic treatments using botulinum neurotoxin
|
|
EP4166107A1
(de)
|
2008-05-09 |
2023-04-19 |
Nuvaira, Inc. |
Systeme, anordnungen und verfahren zur behandlung eines bronchialbaums
|
|
JPWO2010013495A1
(ja)
*
|
2008-07-31 |
2012-01-05 |
一般財団法人化学及血清療法研究所 |
高度精製ボツリヌス毒素治療剤を有効成分として含有する薬学的組成物およびその利用
|
|
US8270698B2
(en)
|
2008-09-24 |
2012-09-18 |
Merge Healthcare Incorporated |
Anterior commissure and posterior commissure segmentation system and method
|
|
US20100124559A1
(en)
*
|
2008-11-20 |
2010-05-20 |
Allergan, Inc. |
Early Treatment and Prevention of Increased Muscle Tonicity
|
|
CA2745657C
(en)
|
2008-12-04 |
2022-06-21 |
Botulinum Toxin Research Associates, Inc. |
Extended length botulinum toxin formulation for human or mammalian use
|
|
US8849390B2
(en)
|
2008-12-29 |
2014-09-30 |
Cyberonics, Inc. |
Processing for multi-channel signals
|
|
US8588933B2
(en)
|
2009-01-09 |
2013-11-19 |
Cyberonics, Inc. |
Medical lead termination sleeve for implantable medical devices
|
|
EP2246065A1
(de)
*
|
2009-04-29 |
2010-11-03 |
Merz Pharma GmbH & Co. KGaA |
Intrastriatale Botulintoxin-Therapie
|
|
US8786624B2
(en)
|
2009-06-02 |
2014-07-22 |
Cyberonics, Inc. |
Processing for multi-channel signals
|
|
EP2482838A4
(de)
|
2009-09-30 |
2013-04-10 |
Toxcure Inc |
Verwendung von botulinum-neurotoxin zur behandlung von substanzabhängigkeit
|
|
CN102639077B
(zh)
|
2009-10-27 |
2015-05-13 |
赫莱拉公司 |
具有可冷却的能量发射组件的递送装置
|
|
US8911439B2
(en)
|
2009-11-11 |
2014-12-16 |
Holaira, Inc. |
Non-invasive and minimally invasive denervation methods and systems for performing the same
|
|
EP2498705B1
(de)
|
2009-11-11 |
2014-10-15 |
Holaira, Inc. |
Vorrichtung zur gewebebehandlung und stenosekontrolle
|
|
JP2011157331A
(ja)
*
|
2010-02-03 |
2011-08-18 |
Chemo-Sero-Therapeutic Research Inst |
高用量投与が可能なボツリヌス毒素製剤
|
|
US9643019B2
(en)
|
2010-02-12 |
2017-05-09 |
Cyberonics, Inc. |
Neurological monitoring and alerts
|
|
US8892184B2
(en)
|
2010-10-18 |
2014-11-18 |
Siemens Medical Solutions Usa, Inc. |
Systems and methods for reducing interference in a dual modality imaging system
|
|
US8706181B2
(en)
*
|
2011-01-25 |
2014-04-22 |
Medtronic, Inc. |
Target therapy delivery site selection
|
|
WO2012174123A1
(en)
|
2011-06-13 |
2012-12-20 |
Allergan, Inc. |
Treatment of psychological trauma
|
|
US20140140983A1
(en)
|
2011-07-08 |
2014-05-22 |
Allergan, Inc. |
Method for treatment of autonomic nervous system disorders
|
|
US8992941B2
(en)
|
2011-07-08 |
2015-03-31 |
Allergan, Inc. |
Method for treatment of esophageal spasm
|
|
KR20140054055A
(ko)
|
2011-07-14 |
2014-05-08 |
알러간, 인코포레이티드 |
성행위와 관련된 실금의 치료방법
|
|
BR112014001066A2
(pt)
|
2011-07-20 |
2017-02-21 |
Allergan Inc |
toxinas botulínicas para uso em um método para tratamento de depósitos adiposos
|
|
US9393291B2
(en)
|
2012-04-12 |
2016-07-19 |
Botulinum Toxin Research Associates, Inc. |
Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
|
|
EP2649984A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose
|
|
EP2649985A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose (III)
|
|
AU2013246882B2
(en)
|
2012-04-13 |
2017-10-19 |
Lubrizol Advanced Materials, Inc. |
Compounds which inhibit neuronal exocytosis (II)
|
|
EP2649983A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose (II)
|
|
US9005628B2
(en)
|
2012-10-04 |
2015-04-14 |
Dublin City University |
Biotherapy for pain
|
|
US9398933B2
(en)
|
2012-12-27 |
2016-07-26 |
Holaira, Inc. |
Methods for improving drug efficacy including a combination of drug administration and nerve modulation
|
|
US9463186B2
(en)
|
2013-04-15 |
2016-10-11 |
Northwestern University |
Treatment for dopaminergic disorders
|
|
GB201312317D0
(en)
|
2013-07-09 |
2013-08-21 |
Syntaxin Ltd |
Cationic neurotoxins
|
|
US10149893B2
(en)
|
2013-09-24 |
2018-12-11 |
Allergan, Inc. |
Methods for modifying progression of osteoarthritis
|
|
US9216210B2
(en)
|
2013-12-23 |
2015-12-22 |
Dublin City University |
Multiprotease therapeutics for chronic pain
|
|
US9901627B2
(en)
|
2014-07-18 |
2018-02-27 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US9950194B2
(en)
|
2014-09-09 |
2018-04-24 |
Mevion Medical Systems, Inc. |
Patient positioning system
|
|
WO2016081767A1
(en)
|
2014-11-19 |
2016-05-26 |
Neurosigma, Inc. |
Trigeminal neurostimulation based upon pulse counting and chronobiology
|
|
WO2016097848A1
(en)
|
2014-12-18 |
2016-06-23 |
Dexcel Pharma Technologies Ltd. |
Alternating and semi-alternating poly(ester-anhydride) copolymers
|
|
HUE053935T2
(hu)
|
2015-01-09 |
2021-08-30 |
Ipsen Bioinnovation Ltd |
Kationos neurotoxinok
|
|
GB201517450D0
(en)
|
2015-10-02 |
2015-11-18 |
Ipsen Biopharm Ltd |
Method
|
|
GB201607901D0
(en)
|
2016-05-05 |
2016-06-22 |
Ipsen Biopharm Ltd |
Chimeric neurotoxins
|
|
EP3263710A1
(de)
|
2016-07-01 |
2018-01-03 |
Ipsen Biopharm Limited |
Herstellung von aktivierten clostridien-neurotoxinen
|
|
WO2018060351A1
(en)
|
2016-09-29 |
2018-04-05 |
Ipsen Biopharm Limited |
Hybrid neurotoxins
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
AU2017406466A1
(en)
|
2017-03-29 |
2019-10-17 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising biodegradable copolymers
|
|
CN106890196A
(zh)
*
|
2017-04-07 |
2017-06-27 |
青岛东海药业有限公司 |
酪酸梭菌在制备预防或治疗帕金森病制剂中的应用
|
|
JP2021514010A
(ja)
*
|
2018-02-20 |
2021-06-03 |
エッジワイズ セラピューティクス， インコーポレイテッド |
運動障害を処置するための方法および組成物
|
|
US20210187194A1
(en)
|
2018-02-26 |
2021-06-24 |
Ipsen Biopharm Limited |
Use of Ultrasound to Guide Injection of Non-cytotoxic Protease
|
|
GB201812746D0
(en)
|
2018-08-06 |
2018-09-19 |
Gill Steven S |
Method
|
|
CN109106943B
(zh)
*
|
2018-11-05 |
2021-04-20 |
中国科学院上海有机化学研究所 |
抗癫痫的毒素Martentoxin及其应用
|
|
EP3993825A1
(de)
*
|
2019-07-05 |
2022-05-11 |
Allergan, Inc. |
Verfahren zur behandlung und hemmung des fortschreitens von anfällen
|
|
US10967052B1
(en)
|
2019-10-18 |
2021-04-06 |
Penland Foundation |
Treatment of dyslexia using botulinum toxin
|
|
US11241479B2
(en)
|
2019-10-18 |
2022-02-08 |
Penland Foundation |
Treatment methods using botulinum toxins
|
|
US10987411B1
(en)
|
2019-10-18 |
2021-04-27 |
Penland Foundation |
Treatment of chronic obstructive pulmonary disease using botulinum toxin
|
|
US10960061B1
(en)
|
2019-10-18 |
2021-03-30 |
Penland Foundation |
Treatment of amyotrophic lateral sclerosis using botulinum toxin
|
|
KR102520625B1
(ko)
|
2019-10-18 |
2023-04-12 |
펜랜드 파운데이션 |
치료에 사용하기 위한 보톨리늄 독소
|
|
US10960060B1
(en)
|
2019-10-18 |
2021-03-30 |
Penland Foundation |
Treatment of cardiac arrhythmia using botulinum toxin
|
|
US10973873B1
(en)
|
2019-10-18 |
2021-04-13 |
Penland Foundation |
Treatment of asthma using botulinum toxin
|
|
US11090371B1
(en)
|
2019-10-18 |
2021-08-17 |
Penland Foundation |
Treatment of cirrhosis using botulinum toxin
|
|
WO2021137667A1
(ko)
*
|
2019-12-30 |
2021-07-08 |
주식회사 에이티지씨 |
보툴리눔 신경독소를 포함하는 파킨슨병 치료용 조성물 및 이를 이용한 파킨슨병 치료 방법
|
|
CN113832069B
(zh)
*
|
2020-11-30 |
2024-01-30 |
河南农业大学 |
丁酸梭菌及其应用
|
|
GB202100566D0
(en)
*
|
2021-01-15 |
2021-03-03 |
Ipsen Biopharm Ltd |
Treatment of brain damage
|
|
GB202103372D0
(en)
|
2021-03-11 |
2021-04-28 |
Ipsen Biopharm Ltd |
Modified clostridial neurotoxins
|
|
WO2023287728A1
(en)
|
2021-07-12 |
2023-01-19 |
Penland Foundation |
Treatment of diabetes and chronic pancreatitis using botulinum toxin
|
|
WO2023287729A1
(en)
|
2021-07-12 |
2023-01-19 |
Penland Foundation |
Treatment of acute and chronic kidney disease
|
|
CN113491763B
(zh)
*
|
2021-08-19 |
2023-11-24 |
苏州人本药业有限公司 |
眼镜蛇神经毒素及其制剂在制备预防和/或治疗帕金森病的药物中的应用
|
|
GB202202719D0
(en)
|
2022-02-28 |
2022-04-13 |
Neurochase Tech Ltd |
Port
|
|
AU2023351434A1
(en)
|
2022-09-30 |
2025-03-06 |
Ipsen Biopharm Limited |
Clostridial neurotoxin for use in a treatment of bladder pain syndrome
|